# Oral Dosage Form New Animal Drugs; Oxfendazole Suspension
> **Food and Drug Administration** · Final rule. · Published 2007-03-09 · Effective 2007-03-09 · 72 FR 10595
## Document
- **Document number:** E7-4205
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 10595
- **CFR reference:** 21 CFR 520
- **Publication date:** 2007-03-09
- **Effective date:** 2007-03-09
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADA provides for over-the-counter (OTC) marketing status for oral use of oxfendazole suspension in cattle.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/03/09/E7-4205/oral-dosage-form-new-animal-drugs-oxfendazole-suspension)
---
*AI Analytics · CC0 1.0*